Technology | Advanced Visualization | December 04, 2017

Vital Unveils Newest Vitrea Advanced Visualization Release at RSNA 2017

Version 7 features new nuclear imaging applications, radiotherapy treatment planning

Vital Unveils Newest Vitrea Advanced Visualization Release at RSNA 2017

December 4, 2017 — Vital Images unveiled the newest version of Vitrea Advanced Visualization software, the cornerstone of its imaging platform, at the 2017 Radiological Society of North America (RSNA) annual meeting, Nov. 26-Dec. 1 in Chicago. The new release, dubbed Version 7, includes numerous product enhancements and state-of-the-art modality applications.

Performance and workflow efficiency along with a lightweight integration engine ensure users have standardized toolsets across all modalities and all “ologies.”   

A sample of Vital’s newest innovations includes:               

  • Intuitive user interface with a dark color scheme for better viewing in the reading room;
  • Semi-automated transcatheter aortic valve replacement (TAVR) valve plane measurements;
  • Updated stent manufacturer templates and Fleischner Criteria for 2017;
  • 4-D CT (computed tomography) Brain Perfusion addition for DSA shuttle perfusion and 4-D support for thin slice axial and helical data;
  • Multi Modality Viewer updates for X-ray angiography (XA), positron emission tomography (PET) and PET/CT;
  • CT Colon Analysis with electronic bowel cleansing (EBC);
  • Stereolithography (STL) export for enterprise users with new 3-D-printed anatomical models on display in the Vital booth;
  • 4K high resolution monitor support;
  • Increased rendering performance and faster time to first image; and
  • Shared modified presets across the organization.

The company also announced three new partner applications integrated with Vitrea Advanced Visualization.

4DM, powered by Invia, is state-of-the-art software for nuclear cardiology quantification, review and reporting for single photon emission computed tomography (SPECT), PET and hybrid-CT patient studies. 4DM enables physicians to assess a patient’s cardiac health by reviewing patient images and 4DM quantifications all in a single, convenient and configurable application.

Building on Mirada Medical’s vision to provide simple and accurate solutions to complex image analysis problems in the diagnosis and treatment of cancer, Vital is pleased to announce two new integrated applications.

Mirada Medical also has two new integrated applications related to complex image analysis in the diagnosis and treatment of cancer. Mirada RTx delivers software tools for radiation therapy treatment planning that bring increased functionality, speed and accuracy to the planning process. Mirada Nuclear Medicine (NM) Workflows provides flexible display protocols and workflows that allow quick and easy reading of NM studies.

For more information: www.vitalimages.com

Related Content

Intelerad Medical Systems, a leader in enterprise workflow solutions, announced the acquisition of Radius, a private cloud platform provider based in the Nashville, Tenn., metropolitan area.
News | Enterprise Imaging | August 05, 2020
August 5, 2020 — Intelerad Medical Systems, a leader in enterprise workflow solutions, announced the acquisition of
Keeping the health and safety of of the HIMSS audience in mind, the conference moves to August 9-13 in Las Vegas
News | HIMSS | August 03, 2020
August 3, 2020 —  The Healthcare Informatio...
Candelis, Inc., a leading provider of innovative and cost-effective enterprise healthcare solutions, and VasoTechnololgy, a subsidiary of the Vaso Corporation, announced an agreement to distribute Candelis' suite of image management PACS solutions and cloud services, including ImageGrid, ImageGrid Mini PACS and ASTRA Cloud.
News | Enterprise Imaging | July 29, 2020
July 29, 2020 — Candelis, Inc., a leading provider of innovative and cost-effective enterprise healthcare solutions,
Clearing medical device cybersecurity requirements from DoD delivers even more safety assurance for customers
News | Cybersecurity | July 23, 2020
July 23, 2020 — Carestream Health’s ImageView software has received the Risk Management Framework Authority to Operat
In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.  http://jnm.snmjournals.org/content/early/2020/07/16/jnumed.120.249748.full.pdf+html

In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.

 

News | Coronavirus (COVID-19) | July 22, 2020 | Dave Fornell, Editor
July 22, 2020 — One of the first studies has been published that looks at the use of...
Tau (blue) and amyloid (orange) distribution patterns for super-agers, normal-agers and MCI patients, when compared to a group of younger, healthy, cognitively normal, amyloid-negative individuals. Brain projections are depicted at an uncorrected significance level of p < .0001. Color bars represent the respective t-statistic. Image courtesy of Merle C. Hoenig, Institute for Neuroscience and Medicine II - Molecular Organization of the Brain, Research Center Juelich, Juelich, Germany, and Department of Nucle

Tau (blue) and amyloid (orange) distribution patterns for super-agers, normal-agers and MCI patients, when compared to a group of younger, healthy, cognitively normal, amyloid-negative individuals. Brain projections are depicted at an uncorrected significance level of p < .0001. Color bars represent the respective t-statistic. Image courtesy of Merle C. Hoenig, Institute for Neuroscience and Medicine II - Molecular Organization of the Brain, Research Center Juelich, Juelich, Germany, and Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany.

News | PET Imaging | July 16, 2020
July 16, 2020 — Super-agers, or individuals whose cognitive skills are above the norm even at an advanced age, have b